Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

BRAIN Biotech AG (ETR:BNN) just released its latest yearly report and things are not looking great. It was a pretty negative result overall, with revenues of €55m missing analyst predictions by ...

Revenue: €55.5m (down 1.3% from FY 2023). Net loss: €11.1m (loss widened by 34% from FY 2023). €0.51 loss per share (further deteriorated from €0.38 loss in FY 2023). Revenue missed ...

NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts aSAH is bleeding over the brain’s surface in the subarachnoid space between the brain and the skull, which contains blood vessels that ...

BRAIN Biotech AG (ETR:BNN) just released its latest yearly report and things are not looking great. It was a pretty negative result overall, with revenues of €55m missing analyst predictions by 4.0%.

Revenue: €55.5m (down 1.3% from FY 2023). Net loss: €11.1m (loss widened by 34% from FY 2023). €0.51 loss per share (further deteriorated from €0.38 loss in FY 2023). Revenue missed analyst estimates ...

Two studies published in the latest issue of Science have revealed that birds, reptiles, and mammals have developed complex brain circuits independently, despite sharing a common ancestor.

While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28 ...